scholarly journals Cell-based therapies for ischemic cardiomyopathy : investigations of intramyocardial retention and safety of high dose intracoronary delivery of c-kit positive cardiac progenitor cells, and therapeutic utility of a novel population of cardiac mesenchymal stem cells expressing stage-specific embryonic antigen-3 (SSEA-3).

2016 ◽  
Author(s):  
Matthew Keith
2014 ◽  
Vol 20 (7-8) ◽  
pp. 1314-1324 ◽  
Author(s):  
Haiping He ◽  
Tokiko Nagamura-Inoue ◽  
Hajime Tsunoda ◽  
Miki Yuzawa ◽  
Yuki Yamamoto ◽  
...  

2018 ◽  
Vol 596 (12) ◽  
pp. 2359-2379 ◽  
Author(s):  
Patrick Vigneault ◽  
Patrice Naud ◽  
Xiaoyan Qi ◽  
Jiening Xiao ◽  
Louis Villeneuve ◽  
...  

2019 ◽  
Vol 2 (1) ◽  
pp. 1-9
Author(s):  
Bobby Indra Utama

Amniotic fluid is a liquid that fills the amniotic cavity which has defense and nutritional functions in fetal development. Human aterm amniotic fluid can be an ideal alternative as a source of mesenchymal stem cells, originating from the neonate. Preclinical studies of second and third trimester amnion fluid cells confirmed the number of potential donors from this wasted material. In several studies, AF-MSCs express mesenchymal markers such as CD90, CD73 (SH3, SH), CD105 (SH2), CD29, CD166, CD49e, CD58 and CD44 (MHC class I). These cells also express HLA-ABC antigens, CD 34, CD 45 which are hematopoietic markers, and endothelial CD31 markers. There is no expression of CD10, CD11b, CD14, CD34, CD117, EMA and HLA-DR, DP, DQ antigens. Most of AF-MSCs have pluripotent properties which are characterized by the discovery of octamer binding protein 3/4 (Oct-3/4), transcription factors Nanog (Nanog), and stage-specific embryonic antigen 4 (SSEA-4) on RT-PCR examination. From this study, 8 million cells was isolated. These cells will be used for research on pelvic organ prolapse therapy by using AF-MSCs. AF-MSCs isolation totally takes 6 weeks. From 1 flask, 2 million of stem cells was obtained. Keywords: amniotic fluid, AF-MSCs


2015 ◽  
Vol 99 (2) ◽  
pp. 605-611 ◽  
Author(s):  
Chani Hodonsky ◽  
Lakshmi Mundada ◽  
Shuyun Wang ◽  
Russell Witt ◽  
Gary Raff ◽  
...  

2008 ◽  
Vol 374 (1) ◽  
pp. 11-16 ◽  
Author(s):  
Chiaki Nakanishi ◽  
Masakazu Yamagishi ◽  
Kenichi Yamahara ◽  
Ikuo Hagino ◽  
Hidezo Mori ◽  
...  

2019 ◽  
Vol 2 (1) ◽  
pp. 1-9
Author(s):  
Bobby Indra Utama

Amniotic fluid is a liquid that fills the amniotic cavity which has defense and nutritional functions in fetal development. Human aterm amniotic fluid can be an ideal alternative as a source of mesenchymal stem cells, originating from the neonate. Preclinical studies of second and third trimester amnion fluid cells confirmed the number of potential donors from this wasted material. In several studies, AF-MSCs express mesenchymal markers such as CD90, CD73 (SH3, SH), CD105 (SH2), CD29, CD166, CD49e, CD58 and CD44 (MHC class I). These cells also express HLA-ABC antigens, CD 34, CD 45 which are hematopoietic markers, and endothelial CD31 markers. There is no expression of CD10, CD11b, CD14, CD34, CD117, EMA and HLA-DR, DP, DQ antigens. Most of AF-MSCs have pluripotent properties which are characterized by the discovery of octamer binding protein 3/4 (Oct-3/4), transcription factors Nanog (Nanog), and stage-specific embryonic antigen 4 (SSEA-4) on RT-PCR examination. From this study, 8 million cells was isolated. These cells will be used for research on pelvic organ prolapse therapy by using AF-MSCs. AF-MSCs isolation totally takes 6 weeks. From 1 flask, 2 million of stem cells was obtained.


2011 ◽  
Vol 317 (18) ◽  
pp. 2661-2670 ◽  
Author(s):  
Feng Wei ◽  
Tingzhong Wang ◽  
Juanjuan Liu ◽  
Yuan Du ◽  
Aiqun Ma

Sign in / Sign up

Export Citation Format

Share Document